Table 2.
Characteristic of Staphylococcus saprophyticus isolated from women with urinary tract infections
| ID number | Age | Biofilm formation | Dnase | PK | SM | mecA | ARPs | MDR |
|---|---|---|---|---|---|---|---|---|
| 1 | 29 | Strong | — | — | D | — | C, CD, E | + |
| 2 | 33 | Strong | — | — | D | — | E, T | — |
| 3 | 39 | Weak | — | D | — | — | CIP, E, GN, T | + |
| 4 | 27 | Moderate | — | D | — | — | C, CIP, E, GN | + |
| 5 | 27 | Strong | — | D | — | + | CIP, CD, T, FOX | + |
| 6 | 28 | Strong | — | — | D | — | CD, E, GN | + |
| 7 | 45 | Moderate | — | — | D | + | CD, E, T, FOX | + |
| 8 | 35 | Weak | — | D | — | + | SXT, CD, T, FOX | + |
| 9 | 33 | Weak | — | D | — | — | CD, T | — |
| 10 | 42 | Strong | — | — | D | — | CIP, CD, E | + |
| 11 | 47 | — | — | — | — | — | CD, E, T | + |
| 12 | 43 | — | — | — | — | — | C, CD, E, GN, T | + |
| 13 | 22 | Strong | — | — | D | + | SXT, C, CIP, CD, T, FOX | + |
| 14 | 28 | Weak | — | — | D | — | CIP, CD, E, T | + |
| 15 | 32 | — | — | — | — | — | CD, E | — |
| 16 | 36 | Moderate | — | — | D | + | CIP, CD, FOX | + |
| 17 | 21 | — | — | — | — | — | CD, GN | — |
| 18 | 51 | Moderate | — | — | D | + | CIP, CD, GN, FOX | + |
| 19 | 53 | Strong | — | — | D | + | SXT, C, CD, GN, FOX | + |
| 20 | 36 | Weak | — | D | — | — | CIP, GN | — |
| 21 | 37 | Weak | — | D | — | + | C, RP, FOX | + |
| 22 | 40 | — | — | — | — | — | E | — |
| 23 | 34 | — | — | — | — | — | E | — |
| 24 | 22 | Moderate | — | — | D | — | C, CD | — |
| 25 | 26 | Moderate | — | — | D | + | SXT, CD, FOX | + |
| 26 | 39 | — | — | — | — | — | CIP, CD, E | + |
| 27 | 43 | Moderate | — | — | D | — | CIP, C, CD, E, GN | + |
| 28 | 27 | Strong | — | — | D | + | E, GN, RP, T, FOX | + |
| 29 | 41 | Weak | — | D | — | — | CIP, C, E, GN | + |
| 30 | 25 | — | — | — | — | — | E, GN | — |
| 31 | 36 | Moderate | — | — | D | + | E, T, FOX | + |
| 32 | 33 | — | — | — | — | — | CIP, GN | — |
| 33 | 30 | Moderate | — | — | D | — | E, GN, T | + |
| 34 | 30 | Strong | — | — | D | — | E, GN, FOX | + |
| 35 | 28 | Weak | — | D | — | — | — | — |
| 36 | 39 | Weak | — | D | — | — | E, GN | — |
| 37 | 47 | Strong | — | — | D | — | C, CIP, E | + |
| 38 | 46 | — | — | — | — | — | — | — |
| 39 | 45 | — | — | — | — | — | E | — |
| 40 | 35 | — | — | — | — | — | — | — |
| 41 | 42 | — | — | — | — | — | C, E | — |
| 42 | 39 | — | — | — | — | — | — | — |
| 43 | 37 | — | — | — | — | — | E | — |
Abbreviations: +, positive; –, negative; ARP,; C, Chloramphenicol; CD, clindamycin; CIP, ciprofloxacin; D, dissolve; E, erythromycin; FOX, cefoxitin; GN, gentamicin; MDR, multidrug resistance; mecA, methicillin-resistant gene; Nd, not done; PK, proteinase K; RP, rifampin; SM, sodium metaperiodate; SXT, sulfamethoxazole-trimethoprim; T, tetracycline.